ArticlePharmaceutical research2019

Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate.

Songtao Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.